Related references
Note: Only part of the references are listed.Intermittent Zoledronic Acid Prevents Bone Loss in Adults after Allogeneic Hematopoietic Cell Transplantation
Parameswaran Hari et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Standardized Nomenclature, Symbols, and Units for Bone Histomorphometry: A 2012 Update of the Report of the ASBMR Histomorphometry Nomenclature Committee
David W. Dempster et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Activated Gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice
Koen Schepers et al.
BLOOD (2012)
Cyclophosphamide Creates a Receptive Microenvironment for Prostate Cancer Skeletal Metastasis
Serk In Park et al.
CANCER RESEARCH (2012)
Osteosclerosis and inhibition of human hematopoiesis in NOG mice expressing human Delta-like 1 in osteoblasts
Ryoji Ito et al.
EXPERIMENTAL HEMATOLOGY (2012)
Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration
Maurizio Rossini et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation
Ok-Joo Sul et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow
Anna Mansour et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation
I. G. Winkler et al.
LEUKEMIA (2012)
Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo
Stefania Lymperi et al.
BLOOD (2011)
Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients
B. L. McClune et al.
BONE MARROW TRANSPLANTATION (2011)
The backbone of progress - preclinical studies and innovations with zoledronic acid
Jonathan R. Green et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection
Dallas Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial
Gareth J. Morgan et al.
LANCET ONCOLOGY (2011)
Advances in the understanding of myeloma bone disease and tumour growth
Shmuel Yaccoby
BRITISH JOURNAL OF HAEMATOLOGY (2010)
MCP-1: Chemoattractant with a role beyond immunity: A review
Amita Yadav et al.
CLINICA CHIMICA ACTA (2010)
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography
Mary L. Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation
Massimo Dominici et al.
BLOOD (2009)
Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis
Nikolaus B. Binder et al.
NATURE MEDICINE (2009)
Bone remodelling: its local regulation and the emergence of bone fragility
T. John Martin et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Limiting factors in murine hematopoietic stem cell assays
Louise E. Purton et al.
CELL STEM CELL (2007)
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases
Theresa A. Guise et al.
CLINICAL CANCER RESEARCH (2006)
Pamidronate reduces bone loss after allogeneic stem cell transplantation
A. P. Grigg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation
A. B. D'Souza et al.
INTERNAL MEDICINE JOURNAL (2006)
Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation
L Tauchmanovà et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength
CA O'Brien et al.
ENDOCRINOLOGY (2004)
Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation
WY Lee et al.
BONE MARROW TRANSPLANTATION (2004)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study
MK Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies
L Tauchmanova et al.
OSTEOPOROSIS INTERNATIONAL (2003)
Mechanisms of osteoporosis after hematopoietic cell transplantation
KN Weilbaecher
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
